Results: The mean values of manganese and Pentraxin-3 of the control group were found to be statistically significantly lower than those of the exposure group, respectively, for Mn levels: 5.04±2.32 µg/L and 11.54±3.09 µg/L; for PTX-3 36.96±24.20 ng/mL and 48.29±27.13 ng/mL; p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: The purpose of this study; it is to compare serum PTX3 levels of manganese-exposed welders with non-exposed people in order to evaluate the nature of manganese-induced inflammatory response.
📊
Key Findings & Data:Material and Method: 51 of whom were exposed to manganese and 52 of whom were volunteers working in the same workplace, were evaluated in the study.
💡
Conclusion & Impact:Results: The mean values of manganese and Pentraxin-3 of the control group were found to be statistically significantly lower than those of the exposure group, respectively, for Mn levels: 5.04±2.32 µg/L and 11.54±3.09 µg/L; for PTX-3 36.96±24.20 ng/mL and 48.29±27.13 ng/mL; p
Aim: The purpose of this study; it is to compare serum PTX3 levels of manganese-exposed welders with non-exposed people in order to evaluate the nature of manganese-induced inflammatory response. Material and Method: 51 of whom were exposed to manganese and 52 of whom were volunteers working in the same workplace, were evaluated in the study. PTX-3 levels were analyzed in the serum samples with ELISA. Mn levels were analyzed in whole blood samples in ICP-MS. Results: The mean values of manganese and Pentraxin-3 of the control group were found to be statistically significantly lower than those of the exposure group, respectively, for Mn levels: 5.04±2.32 µg/L and 11.54±3.09 µg/L; for PTX-3 36.96±24.20 ng/mL and 48.29±27.13 ng/mL; p
OZTAN, O., TÜRKSOY, V. A., DENİZ, S., İRİTAŞ, S. B., TUTKUN, E. (2021). The association between PTX3 and serum manganese levels of welders in comparison with controls: An application of anti-inflammatory biomarker. Journal of Health Sciences and Medicine, Cilt: 4 - Sayı: 4, 511–515. https://ajindex.com/articles/776900
Das AP, Sukla LB, Pradhan N, Nayak S. Manganese biomining: A review. Bioresour Technol 2011; 102: 7381–7. O’Neal SL, Zheng W. Manganese Toxicity Upon Overexposure: a Decade in Review Vol. 2, Current environmental health reports. Springer; 2015. p. 315–28.
Zhaojun W, Lin W, Zhenyong W, Jian W, Ran L. Effects of manganese deficiency on serum hormones and biochemical markers of bone metabolism in chicks. J Bone Miner Metab 2013; 31: 285–92.
Aguirre JD, Culotta VC. Battles with iron: Manganese in oxidative stress protection. J Biol Chem 2012; 287: 13541–8.
Balachandran RC, Mukhopadhyay S, McBride D, Veevers J, Harrison FE, Aschner M, et al. Brain manganese and the balance between essential roles and neurotoxicity. J Biol Chem 2020; 295: 6312–29.
Martinez-Finley EJ, Gavin CE, Aschner M, Gunter TE. Manganese neurotoxicity and the role of reactive oxygen species. Free Radic Biol Med 2013; 62: 65–75. Guilarte TR. Manganese neurotoxicity: New perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates. Front Aging Neurosci 2013; 5: 1–10.
Yamada M, Ohno S, Okayasu I, et al. Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 1986; 70: 273–8.
Benedetto A, Au C, Avila DS, Milatovic D, Aschner M. Extracellular dopamine potentiates Mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in caenorhabditis elegans. PLoS Genet 2010; 6. Dobson AW, Weber S, Dorman DC, Lash LK, Erikson KM, Aschner M. Oxidative stress is induced in the rat brain following repeated inhalation exposure to manganese sulfate. Biol Trace Elem Res 2003; 93: 113–25.
Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3. J Clin Immunol 2008; 28: 1–13.
Padeh S, Farzam N, Chayen G, Gerstein M, Berkun Y. Pentraxin 3 is a marker of early joint inflammation in patients with juvenile idiopathic arthritis. Immunol Res 2013; 56: 444–50.
Uysal S, Yılmaz FM, Karatoprak K, Artüz F, Cumbul NU. The levels of serum pentraxin3, CRP, fetuin-A, and insulin in patients with psoriasis. Eur Rev Med Pharmacol Sci 2014;18: 3453-8.
Karakas MF, Buyukkaya E, Kurt M, et al. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris. J Investig Med 2013; 61: 278–85.